Age and gender related changes in free radical pathology and antioxidant defense in Schizophrenia

Asian Journal of Biochemistry

Volumn 3, Issue 3, 2008, Pages 143-152

  Uma Devi, P ^a   Chinnaswamy, P ^b  

^a DR N G P ARTS AND SCIENCE COLLEGE   (India)

^b KOVAI MEDICAL CENTER AND HOSPITAL   (India)

Author keywords

Antioxidant enzymes; Gender; Malondialdehyde (MDA); Schizophrenia; Young and elderly subjects

Indexed keywords

EID: 44449100275     PISSN: 18159923     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajb.2008.143.152     Document Type: Article

References (49)

1. Aebi, H., 1974. Catalase. In: Methods of Enzymatic Analysis, Bergmeyer, H.U. (Ed.). Academic Press: New York, London, pp: 673-677.
2. Afanas'ev, I.B., 2005. Free radical mechanism of aging processes under physiological conditions. Biogerontology, 6: 283-290.
3. Akila, V.P., H. Harishchandra, V. D'souza and Benedicta D'souza, 2007. Age related changes in lipid per oxidation and antioxidants in elderly people. Indian J. Clin. Biochem., 22: 131-134.
4. Akyol, O., S.S. Zoroǧlu, F. Armutcu, S. Sahin and A. Gurel, 2004. Nitric oxide as a psychopathological factor in neuropsychiatric disorders. In vivo, 18: 377-390.
5. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-Association).
6. Andorn, A.C., R.S. Britton and B.R. Bacon, 1999. Evidence that lipid per oxidation and total iron are increased in Alzheimer's brain. Neurobiol. Aging, 11: 316.
7. Ansari, K.U., 1996. Free radical induced diseases. JIMA, 94: 238-239.
8. Bauer, V. and F. Bauer, 1999. Reactive oxygen species as mediators of tissue protection and injury. Gen. Physiol. Biophys., 18: 7-14.
9. Benedicta, D. and D. Vivian, 2003. Oxidative injury and antioxidant vitamins E and C in Schizophrenia. Ind. J. Clin. Biochem., 18: 87-90
10. Beutler, E., 1984. Red Cell Metabolism: A Manual of Biochemical Methods. Grune and Stratton Orlando, FL., pp: 68-73.
11. Bocchetta, A., 2003. Psychotic Mania in Glucose-6-Phosphate-Dehydrogenase-Deficient Subjects. Ann. Gen. Hosp. Psychiatry, 2: 6. Published online 2003 June 13. doi:10.1186/ 1475-2832-2-6.
12. Bowman, J.E., G.J. Brewer, H. Frischer, J.L. Carter, R.B. Eisenstein and C. Bayrakci, 1965. A re-evaluation of the relationship between glucose-6-phosphate dehydrogenase deficiency and the behavioral manifestations of schizophrenia. J. Lab. Clin. Med., 65: 222-227.
13. Chance, 1954. Catalases and peroxidases, Part II. Special Methods. Methods Biochem. Anal., 1: 408-424.
14. Chatterjea, M.N. and R. Shinde, 2006. Textbook of Medical Biochemistry. 6th Edn. Jaypee Brothers Medical Publisers (p) Ltd., pp: 93-94.
15. Das, S., S. Varisht, R. Shehlata, N. Das and L.M. Srivastava, 2000. Correlation between total antioxidant status and lipid per oxidation in hyper cholesterolaemia. Curr. Sci., 78: 486-487.
16. Dern, R.J., M.F. Glynn and G.J. Brewer, 1963. Studies on the correlation of the genetically determined trait, glucose-6-phosphate dehydrogenase deficiency, with behavioral manifestations in schizophrenia. J. Lab. Chn. Med., 62: 319-329.
17. Devasagayam, T.P.A., K.K. Boloor and T. Ramasarma, 2003. Indian J. Biochem. Biophy., 40: 300-308.
18. D'Souza, B. and V. D'Souza, 2002. Oxidative injury and antioxidant vitamin E in schizophrenia. Ind. J. Clin. Biochem., 18: 87-90.
19. Fieve, R.R., G. Brauninger, J. Fleiss and G. Cohen, 1965. Glucose-6-phosphate dehydrogenase deficiency and schizophrenic behavior. J. Psychiatr. Res., 3: 255-262 (doi: 10.1016/0022-3956(65)90006-3).
20. Frankenburg, F.R., 2006. Schizophrenia, emedicine Specialities>Medicine, pp: 1-10.
21. Frei, B., 1994. Reactive oxygen species and antioxidant vitamins: Mechanisms of action. Am. J. Med., 97: 5S-13S discussion 22S-28S.
22. Fung, L.W.M. and Y. Zhang, 1990. A method to evaluate the antioxidant system for radicals in erythrocyte membranes. Free Radical Biol. Med., 9: 289-298.
23. Glen, A.I., E.M. Glen, D. F. Horrobin, K. S. Vaddadi, M. Spellman, N. Morse-Fisher, K. Ellis and F. S. Skinner, 1994. A red cell membrane abnormality in a subgroup of schizophrenic patients: Evidence for two diseasbs. Schizophr Res., 12: 53-61.
24. Glenberg, A.J., E.L. Bassuk and S. Schoolnover, 1991. The practitioner's guide to psycho active drugs. Plenum Publishing Co., New York, pp: 143.
25. Glód, B.K., G.A. Czapski and P.R. Haddad, 2000. Estimation of antioxidative properties of phenylacefic acids using Ion-Exclusion Chromatography, Acta Chromatographica, Trends. Anal. Chem., 19: 492. No. 15, 2005, 258-268.
26. Granot, E. and R. Kohen, 2004. Oxidative stress in childhood in health and disease states. Clin. Nutr., 23: 3-11.
27. Gutteridge, J.M.C., 1977. The protective action of superoxide on metal-ion catalysed per oxidation of phospholipids. Biochem. Biophys. Res, Commun., 77: 379-386.
28. Gutteridge., J.M.C. and G.J. Quinlan, 2000. Caeruloplasmin Ferroxidase Activity in Experimental Protocols for Reactive Oxygen and Nitrogen Species, Taniguchi, N. and J.M.C. Gutterige (Eds.). Oxford University Press, pp: 114-115.
29. Habig, W.H., M.J. Pabst and W.B. Jakoby, 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., pp: 7130-7139.
30. Haliwell, B., 1989. Oxidants and central nervous system. Some fundamental questions. Acta Neurol. Scand., 126: 23-33.
31. Halliwell, B., 1994. Free radicals, antioxidants and human diseases: Curiosity, cause or consequence? Lancet, 344: 721-724.
32. Herkenl, H., E. Uz, H. Ozvurt, S. Sogut, O. Virit and O.Akyol, 2001. Evidence that the activities of etythrocyte free radical scavenging enzymes and the products of lipid per oxidation axe increased in different forms of schizophrenia. Mol. Psychiat., 6: 66-73.
33. Horrobin, D.F., M. S. Manku, S. Hillman, A. Iain and M. Glen, 1991. Fatty acid levels in brains of schizophrenics and normal controls. Biol. Psychiat., pp: 795-805.
34. Hothersall, J.S., A.L. Greenbaum and P. McLean, 1982. The functional significance of the pentose phosphate pathway in synaptosomes: Protection against per oxidative damage by catecholamines and oxidants. J. Neurochem., 39: 1325-1332.
35. Hui-Churt Li, Qiao-Zhen Chen, Ying Ma and Jun-Fu Zhou, 2006. Imbalanced free radicals and antioxidant defense systems in schizophrenia: A comparativt study. J. Zhejiang Univ. Sci. B., 7: 981-986.
36. Keshavan, M.S., A.G. Mallinger, J.W. Pettegrew and C. Dipple, 1993. Erythrocyte membrane phospholipids in psychiatric patients. Psychiat. Res., 49: 89-96.
37. Kim et al., 1998. FEBS Lett., 431: 473-475.
38. Lohr, J.B. and J.A. Browning, 1995. Free radical involvement in neuropsychatric illnesses. Psychopharmacol. Bull., 1: 159-165.
39. Mahadik, S.P. and R.E. Soheffer, 1996. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fatty Acids (Review), 55: 45-54.
40. Maker, H. S., C. Weiss, D.J. Silides and G. Cohen, 1981. Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem., 36: 589-593.
41. Mayo, 2006. Schizophrenia. Mayo Foundation for Medical Education and Research (MFMER) mayocli nic.com.Tools for Healthier Lives, pp: 1-2.
42. Nasr, S.J., E. Altman, G. Pscheidt and H.Y. Meltzer, 1982. Glucose-6-phosphate dehydrogenase deficiency in a psychiatric population: A preliminary study. Biol. Psych., 17: 925-928.
43. Ohkawa, H., N. Ohishi and K. Yagi, 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., pp: 351-358.
44. Perry, G., L.M. Sayre and C.S. Atwood et al., 2002. The role of iron and copper in the aetiology of neurodegenerative disorders: Therapeutic implications. CNS Drugs, 16: 339-352.
45. Tabner, B.J., S. Turnbull, O.M.A. El-Agnaf and D. Allsop, 2002. Induction of Cellular Oxidative Stress by the beta-amyloid Peptide Involved in Alzheimer's disease. Free Radical Biol. Med., 32: 1076.
46. Takahashi, K., 2000. Glutathione Peroxidase: Coupled Enzyme Assay, Experimental Protocols for Reactive Oxygen and Nitrogen Species, Taniguchi, N. and J.M.C. Gutterige (Eds.). Oxford University Press, pp: 79-80.
47. Vendemiale, G., I. Grattagliano and E. Altomare, 1999. An update on the role of free radicals and antioxidant defense in human disease. J. Clin. Lab. Res., 29: 49-55.
48. Vilkov, G.A., R.I. Kiroi, E.G. Stepnina, O.B. Smirnova, V.A. Kovalenko and R.A. Trapezontseva, 1991. Lipid per oxidation and microviscosity of erythrocyte membranes in patients with schizophrenia. Zh Neuropatol Psikhiatr., 91: 45-47.
49. Yao, K. Jeffrey, D. Reddy Ravinder and D.P. Van Kammen, 2001. Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications. CNS Drugs, 15: 287-310.